Ceftolozane-Tazobactam Pharmaceutical Compositions
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/793,007, filed Mar 15, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,044,485 | Ceftolozane Antibiotic Compositions In force · Low confidence | Merck Sharp & Dohme LLC | In force | Low confidence | ||
| US 9,320,740 | Ceftolozane-Tazobactam Pharmaceutical Compositions In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 9,872,906 | Ceftolozane Antibiotic Compositions In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 9,925,196 | Ceftolozane-Tazobactam Pharmaceutical Compositions In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 10,420,841 | Ceftolozane Antibiotic Compositions In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | ||
| US 11,278,622 | Ceftolozane Antibiotic Compositions In force · Medium confidence | Merck Sharp & Dohme LLC | In force | Medium confidence | ||
| Application 14/251,381 | Ceftolozane Antibiotic Compositions Abandoned Abandoned Jul 7, 2016 | Merck Sharp & Dohme Corp. | Abandoned | Abandoned Jul 7, 2016 | ||
| Application 15/086,479 | Ceftolozane Antibiotic Compositions Abandoned Abandoned Apr 28, 2017 | Merck Sharp & Dohme Corp. | Abandoned | Abandoned Apr 28, 2017 | ||
| Application 15/895,279 | Ceftolozane-Tazobactam Pharmaceutical Compositions Abandoned Abandoned Oct 29, 2019 | Merck Sharp & Dohme Corp. | Abandoned | Abandoned Oct 29, 2019 |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.